Tickers

1. Composite Trajectory Verdict

Given BYRN's manufacturing and omnichannel distribution model with significant inventory investment and working capital requirements, all three statements carry substantial weight, but the income statement's sharp quarterly reversal and the cash flow statement's persistent negative operating cash flow are most indicative of near-term trajectory.

Composite Trajectory: Mixed

The annual income statement shows improvement (revenue +37.7%, operating income +76% YoY), but the quarterly income statement shows severe deterioration (revenue -42.5%, gross margin collapse to 10.9%, operating loss of $12.8M vs $3.3M income). Cash generation deteriorated annually (operating cash flow swung from +$11.7M to -$1.6M) though the latest six-month period used less cash (-$3.0M vs -$9.2M). The balance sheet shows annual asset growth but a 64% inventory build and 312% receivables increase, while the latest quarter shows total assets falling 19% ($84.5M to $68.4M) and cash declining $4.3M in six months. Annual trends are improving; recent quarterly trends are deteriorating sharply.

2. Red Flags

• Gross margin collapse in Q2 FY2026: Gross margin fell to 10.9% ($1.8M gross profit on $16.4M revenue) from 61.6% ($17.6M on $28.5M) in Q2 FY2025, driven by a $5.9M inventory write-down and $3.5M impairment charge for ammunition production assets (10-Q 2026-05-31, Condensed Statements of Operations).
• Operating cash flow turned negative annually: Net cash used in operating activities was -$1.6M for FY2025 vs +$11.7M for FY2024, despite higher net income ($9.7M vs $12.8M), driven by $12.7M inventory increase and $8.0M receivables increase (10-K 2025-11-30, Consolidated Statements of Cash Flows).
• Inventory and receivables outpaced revenue growth in FY2025: Inventory rose 64% ($32.7M vs $20.0M) and accounts receivable rose 312% ($10.8M vs $2.6M) while revenue grew 37.7% (10-K 2025-11-30, Consolidated Balance Sheets).
• Quarterly revenue declined 42.5% YoY: Q2 FY2026 net revenue of $16.4M vs $28.5M in Q2 FY2025, with both DTC (-34.5%) and Wholesale (-53.8%) channels down (10-Q 2026-05-31, MD&A).
• Net loss in Q2 FY2026: Net loss of $10.1M vs net income of $2.4M in Q2 FY2025 (10-Q 2026-05-31, Condensed Statements of Operations).
• Cash balance declined $7.4M in six months: Cash and equivalents fell from $13.7M (Nov 30, 2025) to $9.4M (May 31, 2026) (10-Q 2026-05-31, Consolidated Statements of Cash Flows).
• GAAP vs non-GAAP divergence widening: FY2025 non-GAAP adjusted EBITDA $16.8M vs GAAP operating income $11.8M; Q2 FY2026 non-GAAP adjusted EBITDA -$0.6M vs GAAP operating loss -$12.8M (10-K 2025-11-30, MD&A; 10-Q 2026-05-31, MD&A).
• Royalty revenue reversal: $0.3M net reversal of previously accrued LATAM royalty revenue in Q2 FY2026 due to revised licensee reporting (10-Q 2026-05-31, Note 10).

3. Earnings Assessment (Income Statement)

Earnings Trajectory: Mixed

Annual results improved: FY2025 revenue rose 37.7% to $118.1M from $85.8M, operating income rose 76% to $11.8M from $6.7M, though net income fell to $9.7M from $12.8M due to a $5.7M tax benefit in FY2024 (10-K 2025-11-30, Consolidated Statements of Operations). Gross margin declined 100 bps to 60.5% from 61.5% on channel mix shift (10-K 2025-11-30, MD&A). Quarterly results deteriorated sharply: Q2 FY2026 revenue fell 42.5% to $16.4M from $28.5M, gross margin collapsed to 10.9% from 61.6% after $9.4M in write-downs and impairments, operating loss was $12.8M vs $3.3M income, and net loss was $10.1M vs $2.4M income (10-Q 2026-05-31, Condensed Statements of Operations). Six-month revenue fell 16.9% to $45.4M from $54.7M with gross margin of 42.2% vs 61.2% (10-Q 2026-05-31, MD&A).

4. Cash Generation Assessment (Statement of Cash Flows)

Cash Trajectory: Mixed

Annual operating cash flow deteriorated: FY2025 used $1.6M vs FY2024 provided $11.7M, a $13.3M swing, driven by $12.7M inventory build and $8.0M receivables increase (10-K 2025-11-30, Consolidated Statements of Cash Flows). Investing cash outflows slowed to $0.5M from $11.2M as marketable securities were sold ($8.8M proceeds) (10-K 2025-11-30, Consolidated Statements of Cash Flows). Financing used $1.3M vs $4.6M, with share repurchases of $1.1M vs $3.8M (10-K 2025-11-30, Consolidated Statements of Cash Flows). Recent six-month period: operating activities used $3.0M vs $9.2M in prior year (less negative), investing used $0.4M vs $0.6M, financing used $1.1M vs provided $0.1M (10-Q 2026-05-31, Consolidated Statements of Cash Flows). Cash balance fell from $16.8M (Nov 2024) to $13.7M (Nov 2025) to $9.4M (May 2026).

5. Balance Sheet Assessment

Balance Sheet Trajectory: Deteriorating

Annual comparison (Nov 2024 to Nov 2025): Total assets grew 17% to $84.5M from $71.9M, but inventory surged 64% to $32.7M from $20.0M and accounts receivable rose 312% to $10.8M from $2.6M; cash declined 18% to $13.7M from $16.8M; total liabilities rose 7% to $18.7M from $17.6M; equity rose 21% to $65.8M from $54.4M (10-K 2025-11-30, Consolidated Balance Sheets). Recent quarter (Nov 2025 to May 2026): Total assets fell 19% to $68.4M from $84.5M; cash fell 31% to $9.4M from $13.7M; inventory fell 7% to $30.4M from $32.7M; accounts receivable fell 59% to $4.4M from $10.8M; property and equipment fell 48% to $4.0M from $7.7M after $3.5M impairment; deferred tax asset rose 79% to $7.4M from $4.1M; total liabilities fell 39% to $11.4M from $18.7M (payables down 43% to $9.0M from $15.9M); equity fell 13% to $57.0M from $65.8M as accumulated deficit widened to $56.4M from $47.1M (10-Q 2026-05-31, Consolidated Balance Sheets).

6. Data Gaps

• Standalone Q3 and Q4 FY2025 quarterly income statements and cash flows (only FY2025 annual and Q1/Q2 FY2026 quarterly data provided)
• FY2023 annual results for three-year annual trend analysis
• Q1 FY2026 quarterly results (only six-month YTD and Q2 provided)
• Detailed breakdown of operating expenses by category for quarterly periods (only aggregate provided in 10-Q)
• Credit facility terms and covenant compliance status (referenced but not detailed in provided excerpts)
• Segment-level operating income/loss for quarterly periods (only revenue and COGS by segment provided)
• Inventory turnover and days sales outstanding metrics for quarterly periods